FeesSafety
Pluang+

OS Therapies appoints Rubenstein PR to lead global communications for its cancer immunotherapy advances

Market News
08 Oct 2026, 16:22 WIB
GlobeNewsWire
View Source
Bullish
OS Therapies appoints Rubenstein PR to lead global communications for its cancer immunotherapy advances

OS Therapies, a clinical-stage oncology company specializing in gene-edited, Listeria-based cancer immunotherapies, has named Rubenstein Public Relations as its Agency of Record to manage global communications. This partnership comes as OS Therapies advances its lead immunotherapy, OST-HER2, which targets HER2-positive tumors and has received multiple FDA and EMA designations. The company is progressing toward regulatory approvals in the US and UK in 2026, aiming to bring its treatments to market for osteosarcoma and other solid tumors. Rubenstein PR will develop a comprehensive campaign to enhance OS Therapies' corporate messaging and brand presence worldwide.

OS Therapies' recent partnership news is presented alongside Pluang's Health-sector market data as of Oct 08, 2026 19:42 WIB. Of 128 priced Health-sector US stocks tradable on Pluang, 34 rose and 88 fell today. Notable movers include CRSP (Crispr Therapeutics AG) at USD 51.26 with a 1-day change of -2.08% and a typical hold time of 77 days, ABEO (Abeona Therapeutics Inc) at USD 5.18 with a 1-day change of +1.97% and a typical hold time of 24 days, and NVAX (Novavax Inc) at USD 11.00 with a 1-day change of -1.96% and a typical hold time of 59 days.

More News

A Race Against Blindness relaunches holiday fundraiser with $125K family prize package including Toyota Sienna and Disney vacation

A Race Against Blindness relaunches holiday fundraiser with $125K family prize package including Toyota Sienna and Disney vacation

A Race Against Blindness has brought back its popular Miles, Magic & Mochas holiday fundraiser, offering supporters a chance to win a prize package valued at $125,000. The package includes a 2026 Toyota Sienna Platinum, a $20,000 Disney vacation awar...

Neutral
25 minutes ago
Shell buys back over 2 million shares as part of its ongoing repurchase program.

Shell buys back over 2 million shares as part of its ongoing repurchase program.

On November 18, 2026, Shell plc repurchased a total of approximately 2.15 million shares across multiple trading venues including the London Stock Exchange and European markets. These shares are being bought back for cancellation under Shell's existi...

Company Fundamentals
Neutral
31 minutes ago
MercadoLibre and Amazon show strong long-term growth despite short-term profit challenges.

MercadoLibre and Amazon show strong long-term growth despite short-term profit challenges.

MercadoLibre and Amazon have both delivered impressive returns over the past decade by continuously growing their customer base, revenue, and profits. MercadoLibre is deliberately sacrificing short-term profits to invest in long-term growth, expandin...

Market News
Bullish
40 minutes ago
Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite potential challenges ahead.

Pfizer set to pay its 352nd consecutive dividend on Dec 7, 2026, despite potential challenges ahead.

Pfizer will pay its 352nd consecutive quarterly dividend on December 7, 2026, maintaining a strong track record for investors. The company faces challenges like a patent cliff, costly acquisitions, and clinical setbacks that could threaten this strea...

Company Fundamentals
Neutral
41 minutes ago
General Mills and Realty Income offer high dividend yields as their stock prices near 52-week lows.

General Mills and Realty Income offer high dividend yields as their stock prices near 52-week lows.

General Mills and Realty Income are trading near their 52-week lows, presenting attractive dividend yields of about 7% and 5.7% respectively. General Mills has a strong dividend history of 127 years and covers its dividend with free cash flow despite...

Market News
Bullish
50 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App